
Sanofi SA
SNYHealthcare|Drug Manufacturers - General|France
$43.50
-0.40 (-0.91%)
DCF (FCF)
$57.37
Tangible Book
$1.80
Graham Number
$12.04
Earnings Power
$35.15
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912",
"203012"
],
"revenue_estimate": [
54099.32,
57813.01,
60258.72,
62591.4,
65141.6
],
"ebit_estimate": [
14027.11,
14895.8,
15735.46,
16745.93,
17950.12
],
"ebitda_estimate": [
17111.65,
17853.25,
19244.7,
20925.04,
21915.8
],
"net_income_estimate": [
11632.45,
12292.4,
13421.95,
14454.34,
15329.25
],
"per_share_eps_estimate": [
5.24,
5.89,
null,
null,
null
],
"eps_nri_estimate": [
4.9,
5.28,
5.77,
5.72,
6.39
],
"dividend_estimate": [
2.41,
2.5,
2.63,
2.84,
2.99
],
"book_value_per_share_estimate": [
34.84,
36.39,
38.32,
38.54,
40.7
],
"pretax_income_estimate": [
11963.88,
12951.04,
14641.09,
17023.58,
18703.05
],
"operating_cash_flow_per_share_estimate": [
4.51,
4.85,
5.76,
6.21,
6.9
],
"roa_estimate": [
6.47,
6.8,
7.37,
7.3,
7.7
],
"roe_estimate": [
12.6,
12.64,
13.52,
13.13,
13.73
],
"gross_margin_estimate": [
74.75,
74.56,
75.55,
76.03,
78.65
],
"operating_cash_flow_estimate": [
11045.11,
11894.45,
14128.72,
15217.05,
16915.73
],
"pettm_estimate": [
8.31,
7.39,
null,
null,
null
],
"long_term_growth_rate_mean": 7.62,
"long_term_revenue_growth_rate_mean": "7.23",
"future_per_share_eps_estimate_growth": 10.02,
"future_eps_nri_estimate_growth": 7.62,
"future_revenue_estimate_growth": 7.23,
"future_ebit_estimate_growth": 5.6,
"future_ebitda_estimate_growth": 8.16,
"future_dividend_estimate_growth": 5.46,
"future_net_income_estimate_growth": 7.54,
"future_pretax_income_estimate_growth": 5.61,
"future_book_value_per_share_estimate_growth": 5.73,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": 1.7,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": 9.7
}
quarterly
{
"date": [
"202603",
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
12198.31,
12552.95,
15314.62,
14033.24,
12754.7,
12959.59,
15896.42,
14644.28
],
"ebit_estimate": [
3259.39,
3208.58,
5194.72,
2775.05,
3773.48,
3420.6,
5600.46,
2976.67
],
"ebitda_estimate": [
1638.88,
3540.34,
4922.05,
3101.44,
null,
null,
null,
null
],
"net_income_estimate": [
2543.16,
2582.6,
4172.67,
2246.12,
2932.27,
2654.53,
4402.96,
2308.48
],
"per_share_eps_estimate": [
0.46,
0.58,
1.03,
0.15,
null,
null,
null,
null
],
"eps_nri_estimate": [
1.04,
1.14,
1.6,
1.02,
null,
null,
null,
null
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
3289.86,
3067.37,
5094.48,
2696.74,
null,
null,
null,
null
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
78.27,
77.85,
78.65,
75.8,
78.2,
78.4,
79,
76.5
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
41.83,
27.02,
36.86,
null,
null,
null,
null,
null
],
"long_term_growth_rate_mean": 7.62,
"long_term_revenue_growth_rate_mean": "7.23",
"future_per_share_eps_estimate_growth": 10.02,
"future_eps_nri_estimate_growth": 7.62,
"future_revenue_estimate_growth": 7.23,
"future_ebit_estimate_growth": 5.6,
"future_ebitda_estimate_growth": 8.16,
"future_dividend_estimate_growth": 5.46,
"future_net_income_estimate_growth": 7.54,
"future_pretax_income_estimate_growth": 5.61,
"future_book_value_per_share_estimate_growth": 5.73,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": 1.7,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": 9.7
}